Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study

By Carpiniello B.   Baita A.   Carta M.G.   Sitzia R.   Macciardi A.M.   Murgia S.   Altamura A.C.  

European Psychiatry, Vol. 17, Iss. 7, 2002-11 ,pp. : 394-398

Elsevier

Access to resources Recommend Favorite

Associations between cortical slow potentials and clinical rating scales in panic disorder: a 1.5- year follow-up study

By Dengler W.   Wiedemann G.   Pauli P.  

European Psychiatry, Vol. 14, Iss. 7, 1999-11 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

A 15-year follow-up study of patients with panic disorder

By Andersch S.   Hetta J.  

European Psychiatry, Vol. 18, Iss. 8, 2003-12 ,pp. : 401-408

Elsevier

Access to resources Recommend Favorite

Clinical Experience with Mirtazapine in the Treatment of Panic Disorder

By Carpenter L.L.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 11, Iss. 2, 1999-06 ,pp. : 81-86

Springer Publishing Company

Access to resources Recommend Favorite

2nd Year Maintenance and Discontinuation of Imipramine in Panic Disorder With Agoraphobia

By Mavissakalian M.R.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 2, 2001-06 ,pp. : 63-67

Springer Publishing Company

Access to resources Recommend Favorite